Regenix Biosciences Limited - Company Profile

It is a healthcare public limited company based in Chennai, Tamil Nadu, India, established in 2006.
2006 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Regenix Biosciences Limited

Regenix Biosciences Limited, a active public limited company, was established on 02 March 2006 in Chennai, Tamil Nadu, India. Engaging in medical consumables & supplies within the manufacturing sector, it holds CIN: U24100TN2006PLC059065. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹15.99 Cr.

Formerly known as Liv Medica Equipments Private Limited, Liv Medica Equipments Limited. It upholds a compliant status. Employing 38 professional, Its leadership includes Malathi Ramamurthy (Director), Manjit Singh Parmar (Director), Krishanamoorthy Nirosha (Cfo). Past directors included Malathi Ramamurthy, Lars Conny Blom, Manjit Singh Parmar. It holds ₹14.70 Cr open charges and ₹8.70 Cr settled loans. Its latest AGM occurred on 22 September 2024, with the balance sheet filed on 31 March 2024. It is based at Jamal Sonu Terrace 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TN2006PLC059065

  • Registration Number

    059065

  • Incorporation Date

    02 March 2006

  • Authorized Capital

    ₹16.00 Cr

  • Paid-Up Capital

    ₹15.99 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 16.00 Cr
  • Paid Up Capital ₹ 15.99 Cr
  • Company Age 19 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 14.70 Cr
  • Satisfied Charges ₹ 8.70 Cr
  • Revenue Growth **** 61.87%
  • Profit Growth **** -39.02%
  • Ebitda **** 103.03%
  • Net Worth -0.74%
  • Total Assets **** 16.21%
Company report

Regenix Biosciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Regenix Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Regenix Biosciences Limited?
Current Directors
Name Designation Appointment Date Status
Malathi Ramamurthy Director 29 Sep 2007 Current
Manjit Singh Parmar Director 01 May 2019 Current
Krishanamoorthy Nirosha Cfo 01 May 2019 Current
Balaji Ramamurthy Director 24 Sep 2023 Current
Odaian Maniraj Ambalam Director 11 Dec 2007 Current
Rukmani Director 01 May 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Oct 2007 Past
Pramod Abcsdd Whole-Time Director 19 Oct 2007 Past
Pramod Abcsdd Director 30 Apr 2022 Past
Pramod Abcsdd Additional Director 20 Sep 2008 Past
Pramod Abcsdd Director 30 Apr 2022 Past
Pramod Abcsdd Additional Director 20 Sep 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Regenix Biosciences.

Regenix Biosciences Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 61.87% increase. The company also saw a substantial fall in profitability, with a 39.02% decrease in profit. The company's net worth dipped by a decrease of 0.74%.

Regenix Biosciences revenue growth over time
Regenix Biosciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 61.87%
*******
*******
*******
*******
Revenue from Operations
*******
 61.13%
*******
*******
*******
*******
Total Assets
*******
 16.21%
*******
*******
*******
*******
Profit or Loss
*******
 -39.02%
*******
*******
*******
*******
Net Worth
*******
 -0.74%
*******
*******
*******
*******
EBITDA
*******
 103.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Regenix Biosciences?

In 2024, Regenix Biosciences had a promoter holding of 89.57% and a public holding of 10.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹147,000,000.00

Satisfied Charges

₹86,972,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 14.50 Cr
  • Central Bank Of India : 0.20 Cr
Latest Charge Details
Date Lender Amount Status
18 Oct 2021 Hdfc Bank Limited ₹14.50 Cr Open
16 Jun 1983 Central Bank Of India ₹2.00 M Open
18 Aug 2006 Uti Bank Limited ₹8.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Regenix Biosciences?

Regenix Biosciences has a workforce of 38 employees as of Apr 13, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Regenix Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Biosciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Regenix Biosciences
Recent Activity within the Organization
  • Annual General Meeting

    Regenix Biosciences Limited last Annual general meeting of members was held on 22 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 14.50 Cr registered on 18 Oct 2021 with Charge ID 100505987 was modified on 03 Apr 2024. was documented.

  • Balance Sheet

    The activity Regenix Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.

  • Director Appointment

    Progress on Balaji Ramamurthy was appointed as a Director was appointed as a Director on 24 Sep 2023 & has been associated with this company since 2 years 4 months . was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 14.50 Cr with Charge ID 100505987 was registered on 18 Oct 2021. was documented.

  • Director Appointment

    Progress on Manjit Singh Parmar was appointed as a Director was appointed as a Director on 01 May 2019 & has been associated with this company since 6 years 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Regenix Biosciences Limited?

The CIN of Regenix Biosciences Limited is U24100TN2006PLC059065.

Where is Regenix Biosciences Limited headquartered?

Regenix Biosciences Limited is headquartered at Jamal Sonu Terrace 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.

When was Regenix Biosciences Limited incorporated?

Regenix Biosciences Limited was incorporated on 02 March 2006.

Who are the current directors of Regenix Biosciences Limited?

The current directors of Regenix Biosciences Limited are

What is the primary industry of Regenix Biosciences Limited?

The primary industry of Regenix Biosciences Limited is Manufacturing.

Is Regenix Biosciences Limited a listed company?

Regenix Biosciences Limited is unlisted.

What is the capital structure of Regenix Biosciences Limited?

The authorized capital of Regenix Biosciences Limited is ₹16.00 Cr, and the paid-up capital is ₹15.99 Cr.

What is the compliance status of Regenix Biosciences Limited?

The compliance status of Regenix Biosciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available